Frontlight ResearchEarly access
Trial site
Duke Blood Cancer Center
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia2 trials
- Diffuse large B-cell lymphoma1 trial
- Myeloproliferative neoplasms1 trial
- Sarcoma1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Allogene Therapeutics1 trial
- Gilead Sciences1 trial
- Kura Oncology, Inc.1 trial
- Takeda1 trial
Running trials
Recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Sarcoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026